Presage Biosciences Receives $3,100,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7293e6ba-d13a-4629-a833-4966b9748c92&Preview=1 - Date
3/16/2010 - Company Name
Presage Biosciences - Mailing Address
Undisclosed Seattle, WA 98101 - Company Description
Presage Biosciences was founded in November, 2008 based on technology invented in the laboratory of Dr. James Olson, a pediatric oncologist focused on brain tumors. Frustrated by a lack of tools to identify pre-existing resistance to oncology drugs in his patients, Dr. Olson’s team developed a strategy to assess tumor responses to drug treatments empirically, before subjecting patients to a treatment cycle, frequently with side effects. Presage is using Dr. Olson’s invention to improve the lives of cancer patients though drug development applications. - Website
http://www.presagebio.com - Transaction Type
Venture Equity - Transaction Amount
$3,100,000 - Transaction Round
Undisclosed - Proceeds Purposes
The idea at Presage is to radically improve the odds that cancer drug candidates will successfully navigate through clinical trials. - M&A Terms
- Venture Investor
Undisclosed
